Literature DB >> 6637400

Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy.

F Tagliavini, G Pilleri, F Gemignani, A Lechi.   

Abstract

A morphometric study of the basal nucleus of Meynert (bnM) has been performed in a 70-year-old man with a 4-year history of pathologically confirmed progressive supranuclear palsy (PSP). An important neuronal loss (52%) was demonstrated in the bnM. This finding has not been previously documented with morphometric methods in PSP, but the involvement of the bnM is well known in other related conditions, i.e., Parkinson's disease, Alzheimer's disease, and Parkinson-dementia complex of Guam. Our findings yield support to the view that the involvement of the bnM, a nucleus with complex connections with various subcortical structures and diffuse cholinergic projections on the neocortex, could play an important role in the physiopatholog of subcortical dementia.

Entities:  

Mesh:

Year:  1983        PMID: 6637400     DOI: 10.1007/BF00697397

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  The isodendritic core of the brain stem.

Authors:  E Ramón-Moliner; W J Nauta
Journal:  J Comp Neurol       Date:  1966-03       Impact factor: 3.215

3.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

4.  Neuron loss in the nucleus basalis of Meynert in parkinsonism-dementia complex of Guam.

Authors:  I Nakano; A Hirano
Journal:  Ann Neurol       Date:  1983-01       Impact factor: 10.422

5.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

6.  Magnocellular nuclei of the basal forebrain project to neocortex, brain stem, and olfactory bulb. Review of some functional correlates.

Authors:  I Divac
Journal:  Brain Res       Date:  1975-08-15       Impact factor: 3.252

7.  Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

Authors:  J M Candy; R H Perry; E K Perry; D Irving; G Blessed; A F Fairbairn; B E Tomlinson
Journal:  J Neurol Sci       Date:  1983-05       Impact factor: 3.181

8.  Basal forebrain neurons in the dementia of Parkinson disease.

Authors:  P J Whitehouse; J C Hedreen; C L White; D L Price
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

9.  Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.

Authors:  E K Perry; P H Gibson; G Blessed; R H Perry; B E Tomlinson
Journal:  J Neurol Sci       Date:  1977-11       Impact factor: 3.181

10.  Progressive supranuclear palsy in the course of subclavian steal syndrome.

Authors:  S Calzetti; F Gemignani; A Lechi; V Pietrini; F Tagliavini
Journal:  Acta Neuropathol Suppl       Date:  1981
View more
  13 in total

1.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.

Authors:  Haruo Hanyu; Tetsuichi Asano; Hirofumi Sakurai; Yuriko Tanaka; Masaru Takasaki; Kimihiko Abe
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

2.  Neuropathological study on the nucleus basalis of Meynert in Pick's disease.

Authors:  K Mizukami; K Kosaka
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Neuronal loss in the basal nucleus of Meynert in a patient with olivopontocerebellar atrophy.

Authors:  F Tagliavini; G Pilleri
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

4.  Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: a positron emission tomographic study.

Authors:  M Asahina; T Suhara; H Shinotoh; O Inoue; K Suzuki; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

5.  Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine.

Authors:  J R Atack; I Litvan; L J Thal; C May; S I Rapoport; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

6.  Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

Authors:  E R Maher; E M Smith; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

7.  Allocortical neurofibrillary changes in progressive supranuclear palsy.

Authors:  H Braak; K Jellinger; E Braak; J Bohl
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Pure akinesia: an atypical manifestation of progressive supranuclear palsy.

Authors:  H Matsuo; H Takashima; M Kishikawa; I Kinoshita; M Mori; M Tsujihata; S Nagataki
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

9.  Neurone loss in the nucleus basalis of Meynert in Creutzfeldt-Jakob disease.

Authors:  T Arendt; V Bigl; A Arendt
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 10.  Tau-driven degeneration of sleep- and wake-regulating neurons in Alzheimer's disease.

Authors:  Caroline H Lew; Cathrine Petersen; Thomas C Neylan; Lea T Grinberg
Journal:  Sleep Med Rev       Date:  2021-08-16       Impact factor: 11.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.